Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 923 of 1,261
  1. US 8178513

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  2. US 8178531

    Antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  3. US 8173362

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted May 8, 2012 · Expires May 3, 2032

    granted
  4. US 8173602

    Detecting CYP24 expression level as a marker for predisposition to cancer

    The Regents of the University of California · Granted May 8, 2012 · Expires May 3, 2032

    granted
  5. US 8173645

    Glucokinase activators

    Takeda San Diego, Inc. · Granted May 8, 2012 · Expires May 3, 2032

    granted
  6. US 8173628

    Steroidal antiestrogens and antiandrogens and uses thereof

    Northwestern University · Granted May 8, 2012 · Expires May 3, 2032

    granted
  7. US 8173615

    TRPM-2 antisense therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 8, 2012 · Expires May 3, 2032

    granted
  8. US 8173663

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 8, 2012 · Expires May 3, 2032

    granted
  9. US 8173666

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted May 8, 2012 · Expires May 3, 2032

    granted
  10. US 8173673

    Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof

    Julius-Maximilians-Universitat Wurzburg · Granted May 8, 2012 · Expires May 3, 2032

    granted
  11. US 8173120

    Method of preventing reduced feed intake in animals and treatment of disease conditions

    Precision Nutrition Pty Ltd · Granted May 8, 2012 · Expires May 3, 2032

    granted
  12. US 8173158

    Methods of treating gastrointestinal disorders independent of the intake of food

    Takeda Pharmaceuticals U.S.A., Inc. · Granted May 8, 2012 · Expires May 3, 2032

    granted
  13. US 8173364

    Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs

    The Regents of the University of California · Granted May 8, 2012 · Expires May 3, 2032

    granted
  14. US 8173392

    In vivo incorporation of unnatural amino acids

    The Regents of the University of California · Granted May 8, 2012 · Expires May 3, 2032

    granted
  15. US 8173360

    Cell death inhibitor

    Takeda Pharmaceutical Company Limited · Granted May 8, 2012 · Expires May 3, 2032

    granted
  16. US 8173635

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 8, 2012 · Expires May 3, 2032

    granted
  17. US 8173123

    Methods of treating colitis involving IL-13 and NK-T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 8, 2012 · Expires May 3, 2032

    granted
  18. US 8173139

    High energy electron beam irradiation for the production of immunomodulators in poultry

    The United States of America, as represented by the Secretary of Agriculture · Granted May 8, 2012 · Expires May 3, 2032

    granted
  19. US 8173424

    Internalizing ErbB2 antibodies

    The Regents of the University of California · Granted May 8, 2012 · Expires May 3, 2032

    granted
  20. US 8173134

    ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them

    Five Prime Therapeutics, Inc. · Granted May 8, 2012 · Expires May 3, 2032

    granted
  21. US 8173115

    Particle compositions with a pre-selected cell internalization mode

    The Board of Regents of the University of Texas System · Granted May 8, 2012 · Expires May 3, 2032

    granted
  22. US 8173135

    Methods for preparing complex multivalent immunogenic conjugates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 8, 2012 · Expires May 3, 2032

    granted
  23. US 8173664

    Modified pyrimidine glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted May 8, 2012 · Expires May 3, 2032

    granted
  24. US 8173815

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted May 8, 2012 · Expires May 3, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.